Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
Aurobindo Pharma Ltd, is a listed public company incorporated on 26 December, 1986. It is classified as a public limited company and is located in Hyderabad, Telangana. It's authorized share capital is INR 666.40 cr and the total paid-up capital is INR 58.08 cr.
Aurobindo Pharma Ltd's operating revenue range is Over INR 500 cr for the financial year ending on 31 March, 2023. It's EBITDA has increased by 17.48% over the previous year. At the same time, it's book networth has increased by 4.66%.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR crores. Based on March 2023 numbers.
13.33%
17.48%
-15.42%
4.66%
127.79%
15.43%
-1.91
0.48
-2.87
-1.63
7.39
0.12
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
All financials
All annual returns
MoA and AoA
Latest financials
Latest annual return
MoA and AoA
Five year financials and ratios
Shareholding and group structure
Litigation and more
Everything in financial report
Peers and financials
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(54)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||||
| Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Performance | |||||
| Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return + | |||||
| Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||||
| Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital | |||||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
State Bank of India
No. of Loans: 1
Total Amount : 2,000.0 cr
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Venkata Ramprasad Reddy Penaka
Shareholder
|
01284132 | 32 years |
| Managing Director | Nityananda Reddy Kambam
Shareholder
|
01284195 | 32 years |
| Whole-time Director | Madan Mohan Reddy Mettu
Shareholder
|
01284266 | 12 years |
| Director | Sarath Chandra Reddy Penaka | 01628013 | 17 years |
| CFO | Santhanam Subramanian
Shareholder
|
<HIDDEN> | 10 years |
| Director | Mangalam Ramasubramanian Kumar | 03628755 | 1 years |
| Director | Savita Mahajan | 06492679 | 7 years |
| Director | Deepali Pant Joshi | 07139051 | 1 years |
| CS | Adi Reddy Baddigam | <HIDDEN> | 9 years |
| Director | Girish Paman Vanvari | 07376482 | 4 years |
| Director | Santanu Mukherjee | 07716452 | 2 years |
| Director | Satakarni Makkapati | 09377266 | 1 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| RANIT AGRO PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Telangana |
| PENAKA PHARMA (INDIA) PRIVATE LIMITED |
Active
|
1.0 L | 1 | Telangana |
| RPR SONS ADVISORS PRIVATE LIMITED |
Active
|
1.0 L | 1 | Telangana |
| HYACINTHS PHARMA PRIVATE LIMITED |
Amalgamated
|
32.5 Cr | 1 | Telangana |
| TRIDENT LIFE SCIENCES LIMITED |
Amalgamated
|
1.6 L | 2 | Telangana |
| RAIDURGAM DEVELOPERS LIMITED |
Active
|
10.0 Cr | 1 | Telangana |
| APL RESEARCH CENTRE LIMITED |
Amalgamated
|
12.3 Cr | 1 | Telangana |
| SENOR ORGANICS PVT LTD |
Amalgamated
|
1.5 Cr | 1 | Telangana |
| AUROZYMES LIMITED |
Amalgamated
|
5.0 L | 1 | Telangana |
| SILICON LIFE SCIENCES PRIVATE LIMITED |
Amalgamated
|
110.0 Cr | 1 | Telangana |
| AUROBINDO ANTIBIOTICS PRIVATE LIMITED |
Active
|
1.0 Cr | 1 | Andhra Pradesh |
| QULE PHARMA PRIVATE LIMITED |
Active
|
10.0 L | 1 | Andhra Pradesh |
| AUROBINDO PHARMA FOUNDATION |
Active
|
1.0 L | 2 | Telangana |
| APITORIA PHARMA PRIVATE LIMITED |
Active
|
99.0 Cr | 2 | Telangana |
| APL HEALTHCARE LIMITED |
Active
|
216.0 Cr | 1 | Telangana |
| PATTANCHERU ENVIRO-TECH LIMITED |
Active
|
2.6 Cr | 1 | Telangana |
| LYFIUS PHARMA PRIVATE LIMITED |
Active
|
10.0 L | 1 | Andhra Pradesh |
| OREMSI PLASTICS PRIVATE LIMITED |
Strike Off
|
1.3 L | 1 | Telangana |
| CUREPRO PARENTERALS LIMITED |
Amalgamated
|
13.3 Cr | 2 | Telangana |
| AURONEXT PHARMA PRIVATE LIMITED |
Amalgamated
|
125.0 Cr | 2 | Telangana |
| THERANYM BIOLOGICS PRIVATE LIMITED |
Active
|
10.0 L | 2 | Telangana |
| AUROZEST PRIVATE LIMITED |
Active
|
10.0 L | 1 | Telangana |
| AURO VACCINES PRIVATE LIMITED |
Active
|
10.0 L | 2 | Telangana |
| CREST EXCIPIENTS LLP |
Strike Off
|
1.3 L | 1 | Telangana |
| EUGIA STERILES PRIVATE LIMITED |
Active
|
44.2 Cr | 1 | Telangana |
| EUGIA PHARMA SPECIALITIES LIMITED |
Active
|
621.0 Cr | 1 | Telangana |
| CURATEQ BIOLOGICS PRIVATE LIMITED |
Active
|
100.0 Cr | 1 | Telangana |
| PRAVESHA INDUSTRIES PRIVATE LIMITED |
Active
|
10.0 Cr | 1 | Telangana |
| EUGIA SEZ PRIVATE LIMITED |
Active
|
4.0 Cr | 1 | Telangana |
| ROSA AVENUES INDIA PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Telangana |
| AXIS CLINICALS INDIA LIMITED |
Strike Off
|
5.0 L | 1 | Telangana |
| PVR CHEMPHAR PRIVATE LIMITED |
Active
|
2.2 Cr | 1 | Telangana |
| AURYN LABS LIMITED |
Strike Off
|
5.0 L | 1 | Telangana |
| SARATH PENAKA ENTERPRISES LLP |
Active
|
1.0 L | 1 | Telangana |
| SHREAS INDUSTRIES LIMITED |
Active
|
400.0 Cr | 1 | Telangana |
| CHOLAMANDALAM INVESTMENT AND FINANCE COMPANY LIMITED |
Active
|
168.1 Cr | 1 | Tamil Nadu |
| AMBUJA CEMENTS LIMITED |
Active
|
439.5 Cr | 1 | Gujarat |
| BHAGIRATH RESURGENCE PRIVATE LIMITED |
Active
|
1.0 L | 1 | Delhi |
| INDIA SHELTER FINANCE CORPORATION LIMITED |
Active
|
53.7 Cr | 1 | Haryana |
| AVANSE FINANCIAL SERVICES LIMITED |
Active
|
125.9 Cr | 1 | Maharashtra |
| GEMINI EDIBLES & FATS INDIA LIMITED |
Active
|
10.3 Cr | 1 | Telangana |
| SATYA MICROCAPITAL LIMITED |
Active
|
66.3 Cr | 1 | Delhi |
| KAN AND MORE PRIVATE LIMITED |
Active
|
1.0 L | 1 | Haryana |
| AMBADI ENTERPRISES LIMITED |
Active
|
48.0 L | 1 | Tamil Nadu |
| COROMANDEL INTERNATIONAL LIMITED |
Active
|
29.5 Cr | 1 | Telangana |
| TVS MOTOR COMPANY LIMITED |
Active
|
47.5 Cr | 1 | Tamil Nadu |
| TVS CREDIT SERVICES LIMITED |
Active
|
254.7 Cr | 1 | Tamil Nadu |
| KOLTE-PATIL DEVELOPERS LIMITED |
Active
|
76.0 Cr | 1 | Maharashtra |
| MENON AND MENON LIMITED |
Active
|
9.9 Cr | 1 | Maharashtra |
| ABCD TECHNOLOGIES LLP |
Active
|
620.0 Cr | 1 | Maharashtra |
| HIMADRI SPECIALITY CHEMICAL LIMITED |
Active
|
49.4 Cr | 1 | West Bengal |
| TRANSACTION SQUARE LLP |
Active
|
1.0 L | 1 | Maharashtra |
| BLUE JET HEALTHCARE LIMITED |
Active
|
36.2 Cr | 1 | Maharashtra |
| TARSONS PRODUCTS LIMITED |
Active
|
10.6 Cr | 1 | West Bengal |
| RATEGAIN TRAVEL TECHNOLOGIES LIMITED |
Active
|
11.8 Cr | 1 | Delhi |
| SUMEDHA FISCAL SERVICES LTD |
Active
|
8.0 Cr | 1 | West Bengal |
| SUVEN LIFE SCIENCES LIMITED |
Active
|
21.8 Cr | 1 | Telangana |
| BANDHAN BANK LIMITED |
Active
|
1,611.0 Cr | 1 | West Bengal |
| FAIRMONEY FINANCIAL SERVICES PRIVATE LIMITED |
Active
|
1.0 L | 1 | Karnataka |
| MUTHOOT HOUSING FINANCE COMPANY LIMITED |
Active
|
81.6 Cr | 1 | Kerala |
| NACL INDUSTRIES LIMITED |
Active
|
19.9 Cr | 1 | Telangana |
| RAINBOW SPECIALITY HOSPITALS PRIVATE LIMITED |
Active
|
18.0 Cr | 1 | Telangana |
| RAINBOW CHILDREN'S MEDICARE LIMITED |
Active
|
101.6 Cr | 1 | Telangana |
| AURO PEPTIDES LIMITED |
Active
|
265.9 Cr | 1 | Telangana |
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| APL Pharma Thai Limited, | Thailand | - | - |
| All Pharma (Shanghai) Trading Corp Ltd, | China | - | - |
| Aurobindo Pharma Industria Farmaceutica Ltda | Brazil | - | - |
| Aurobindo Pharma Produtos Farmaceuticos Ltda | Brazil | - | - |
| Aurobindo Pharma Japan KK, | Japan | - | - |
| Auro Pharma Inc | Canada | - | - |
| Aurobindo Pharma (Pty) Ltd | South Africa | - | - |
| Aurovida Farmaceutica Sa De Cv | Mexico | - | - |
| Aurobindo Pharma Colombia Sas | Colombia | - | - |
| Aurogen South Africa (Pty) Ltd | South Africa | - | - |
| Aurobindo Pharma Saudi Arabia Ltd Co | Saudi Arabia | - | - |
| Aurovitas Pharma (Taizhou) Ltd | China | - | - |
| Aurobindo Pharma USA Inc | United States | - | - |
| Aurolife Pharma LLC | United States | - | - |
| Eugia US LLC (formerly Auromedics Pharma LLC), U.S.A. | United States | - | - |
| Auro Health LLC | United States | - | - |
| Auro AR LLC | United States | - | - |
| Auro Vaccines LLC | United States | - | - |
| AuroLogistics LLC | United States | - | - |
| Acrotech Biopharma LLC | United States | - | - |
| Helix Healthcare B.V. | Netherlands | - | - |
| Agile Pharma B.V | Netherlands | - | - |
| Laboratorios Aurobindo S.L. | Spain | - | - |
| Aurex B.V. (formerly known as Pharmacin B.V.) | Netherlands | - | - |
| Milpharm Limited | United Kingdom | - | - |
| Aurobindo Pharma (Malta) Ltd | Malta | - | - |
| APL Swift Services (Malta) Ltd | Malta | - | - |
| THERANYM BIOLOGICS PRIVATE LIMITED | Telangana | 2022 | ₹ 10.0 L |
| Aurobindo Pharma (Romania) s.r.l | Romania | - | - |
| Pharmacin B.V. (formerly known as Aurex B.V.) | Netherlands | - | - |
| Aurobindo Pharma (Italia) S.r.l | Italy | - | - |
| Arrow Generiques SAS | France | - | - |
| 1980 Puren Pharma GmbH | Germany | - | - |
| Puren Pharma GmbH & Co. KG | Germany | - | - |
| Aurovitas Spain SA | Spain | - | - |
| Aurovitas Pharma Polska | Poland | - | - |
| Generis Farmacêutica SA | Portugal | - | - |
| Generis Phar, Unipessoal Ltda | Portugal | - | - |
| APL HEALTHCARE LIMITED | Telangana | 2006 | ₹ 216.0 Cr |
| AURONEXT PHARMA PRIVATE LIMITED | Telangana | 2009 | ₹ 125.0 Cr |
| AURO PEPTIDES LIMITED | Telangana | 2012 | ₹ 265.9 Cr |
| APITORIA PHARMA PRIVATE LIMITED | Telangana | 2017 | ₹ 99.0 Cr |
| Aurobindo Pharma FZ LLC | United Arab Emirates | - | - |
| PT Aurogen Pharma Indonesia | Indonesia | - | - |
| Auro Science PTY Ltd | Australia | - | - |
| Auro Science LLC | United States | - | - |
| Aurovitas Spol s.r.o (Formerly Apotex (CR) Spol s.r.o.) | Czech Republic | - | - |
| Apotex Europe B.V. | Netherlands | - | - |
| Aurovitas Nederland B.V ( formerly Apotex Nederland B.V.) | Netherlands | - | - |
| Sameko Farma B.V. | Netherlands | - | - |
| Leida pharm B.V | Netherlands | - | - |
| Marel B.V. | Netherlands | - | - |
| Pharma Dossier B.V. | Netherlands | - | - |
| Auro Packaging LLC (w.e.f. 1.4.2019) | United States | - | - |
| Aurobindo NV/SA (w.e.f. 17 December 2019) | Belgium | - | - |
| AUROACTIVE PHARMA PRIVATE LIMITED | Telangana | 2020 | ₹ 100.0 Cr |
| CURATEQ BIOLOGICS PRIVATE LIMITED | Telangana | 2020 | ₹ 100.0 Cr |
| EUGIA STERILES PRIVATE LIMITED | Telangana | 2020 | ₹ 44.2 Cr |
| AUROZEST PRIVATE LIMITED | Telangana | 2020 | ₹ 10.0 L |
| AUROBINDO ANTIBIOTICS PRIVATE LIMITED | Andhra Pradesh | 2020 | ₹ 1.0 Cr |
| MVIYES PHARMA VENTURES PRIVATE LIMITED | Telangana | 2017 | ₹ 150.2 Cr |
| LYFIUS PHARMA PRIVATE LIMITED | Andhra Pradesh | 2020 | ₹ 10.0 L |
| QULE PHARMA PRIVATE LIMITED | Andhra Pradesh | 2020 | ₹ 10.0 L |
| EUGIA SEZ PRIVATE LIMITED | Telangana | 2021 | ₹ 4.0 Cr |
| EUGIA PHARMA SPECIALITIES LIMITED | Telangana | 2013 | ₹ 621.0 Cr |
| Aurobindo Pharma B.V. (formerly known as Actavis B.V.) | Netherlands | - | - |
| CuraTeQ Biologics s.r.o | Czech Republic | - | - |
| Eugia Pharma B.V | Netherlands | - | - |
| Eugia Pharma (Malta) Limited | Malta | - | - |
| Eugia (UK) Limited | United Kingdom | - | - |
| Aurosalud SA De CV | Mexico | - | - |
| Auro PR Inc | Puerto Rico | - | - |
| Eugia Pharma INC | Canada | - | - |
| Eugia Pharma (Australia) PTY Limited | Australia | - | - |
| Eugia Pharma Industria Farmaceutica Limitada | Brazil | - | - |
| Auro PR I LLC (formerly known as Mylan LLC) | Puerto Rico | - | - |
| Aurobindo Pharma Ukraine LLC | Ukraine | - | - |
| Eugia Pharma Colombia S.A.S | Colombia | - | - |
| Auro Steriles LLC | United States | - | - |
| Vespyr Brands, Inc (formerly known as Nurya Brands Inc) | United States | - | - |
| Eugia US Manufacturing LLC | United States | - | - |
| Eugia Injectable Inc | United States | - | - |
| Eugia Inc | United States | - | - |
| AURO VACCINES PRIVATE LIMITED | Telangana | 2021 | ₹ 10.0 L |
| GLS PHARMA LIMITED | Delhi | 2004 | ₹ 1.2 Cr |
| Auromedics Pharma LLC | United States | - | - |
| Aurobindo Pharma GmbH, Germany | Germany | - | - |
| CuraTeQ Biologics GmbH | Switzerland | - | - |
| Apotex spol s.r.o (w.e.f. 8 February 2019 Formerly Apotex (CR)) | Czech Republic | - | - |
The incorporation date of AUROBINDO PHARMA LTD is 26 December, 1986
The authorized share capital of AUROBINDO PHARMA LTD is INR ₹ 666.4 Cr.
The paid-up capital of AUROBINDO PHARMA LTD is INR ₹ 58.1 Cr.
The registered address of AUROBINDO PHARMA LTD is PLOT NO.2, MAITHRIVIHAR, BEHIND MAITHRI VANAM, AMEERPET HYDERABAD Telangana - 500038
The CIN number of AUROBINDO PHARMA LTD is L24239TG1986PLC015190.
Expand
Delete
Collapse
See
details
